Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Thankfully, my new general practitioner helped me access a generic version (tirzepatide)
Mounjaro has shown impressive results during trials with individuals who are overweight or obese, including the following findings: Participants dropped between 5% and 22.5% of their total body weight, compared to individuals taking many existing FDA-approved medications for obesity who lost between 5% and 15%
He looked at insurance claims data in a research letter published in JAMA and found that few patients actually adhere to the drugs for the long term
GLP-1 receptor agonists are generally discontinued before planned conception according to labeling, and phentermine-topiramate has specific fetal toxicity risk because of topiramate-associated oral clefts
Activation of GIP could protect bone density Rapid, substantial weight loss reduces the static and dynamic loads on the skeleton, causing the body to increase bone resorption and decrease bone formation, leading to a decline in bone mineral density (BMD)
